Schonfeld Strategic Advisors LLC Curis Inc Transaction History

Schonfeld Strategic Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.57 - $0.99 $2,508 - $4,356	4,400 Added 10.76%	45,300 $37,000
Q1 2023 May 15, 2023	SELL	$0.51 - $0.78 $45,696 - $69,888	-89,600 Reduced 68.66%	40,900 $24,000
Q4 2022 Feb 14, 2023	SELL	$0.47 - $17.22 $42,453 - $1.56 Million	-90,326 Reduced 40.9%	130,500 $71,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $15.01 $444,415 - $9.01 Million	-600,561 Reduced 73.12%	220,826 $155,000
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $47,374 - $162,141	66,725 Added 8.84%	821,387 $809,000
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $561,780 - $1.25 Million	243,195 Added 47.55%	754,662 $1.8 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $1.95 Million - $3.55 Million	439,067 Added 606.45%	511,467 $2.43 Million
Q3 2021 Nov 16, 2021	SELL	$6.94 - $8.85 $1.51 Million - $1.92 Million	-216,901 Reduced 74.97%	72,400 $567,000
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $192,575 - $420,563	25,849 Added 9.81%	289,301 $2.33 Million
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $881,353 - $1.28 Million	-100,382 Reduced 27.59%	263,452 $2.98 Million
Q4 2020 Feb 16, 2021	BUY	$1.08 - $8.2 $192,492 - $1.46 Million	178,234 Added 96.03%	363,834 $2.98 Million
Q3 2020 Nov 16, 2020	BUY	$0.95 - $1.42 $176,320 - $263,552	185,600 New	185,600 $0

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.